Apyx Medical
APYX
69 hedge funds and large institutions have $154M invested in Apyx Medical in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 24 reducing their positions, and 8 closing their positions.
28% more capital invested
Capital invested by funds: $120M → $154M (+$34.2M)
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
1.03% more ownership
Funds ownership: 52.39% → 53.42% (+1%)
0% more funds holding
Funds holding: 69 → 69 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$1.7M |
| 2 |
Goldman Sachs
New York
|
+$1.41M |
| 3 |
PVI
Pura Vida Investments
New York
|
+$1.07M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$995K |
| 5 |
State Street
Boston,
Massachusetts
|
+$419K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
-$1.13M |
| 2 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$677K |
| 3 |
Morgan Stanley
New York
|
-$535K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$530K |
| 5 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$361K |
APYX Hedge Fund Activity: Q4 2019 in Review
69 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2019, worth a combined $154M — up 28% from $120M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new APYX positions and 8 closed out — a net gain of 1 holder — while 23 added to existing stakes and 24 trimmed.
The largest buyer was Cowen and Company, opening a new position worth an estimated $1.7M. The largest seller was Perkins Capital Management, cutting an estimated $1.13M.
- 69 institutional investors held Apyx Medical (APYX) as of Q4 2019, unchanged from Q3 2019.
- Funds reported $154M of Apyx Medical stock for Q4 2019, up 28% quarter-over-quarter.
- 9 funds opened new Apyx Medical positions in Q4 2019 and 8 closed out, a net change of +1 holder.
- The largest Apyx Medical buyer in Q4 2019 was Cowen and Company, an estimated $1.7M added.
- The largest Apyx Medical seller in Q4 2019 was Perkins Capital Management, an estimated $1.13M sold.
Based on aggregated 13F filings for Q4 2019.